{"composite_breakdown_label":"","computation_units":"","copyright":"","data_footnote":"","data_non_statistical":false,"data_notice_class":"","data_notice_heading":"","data_notice_text":"","data_show_map":false,"data_start_values":[],"embedded_feature_footer":"","embedded_feature_html":"","embedded_feature_tab_title":"","embedded_feature_title":"","embedded_feature_url":"","expected_disaggregations":[],"graph_annotations":[],"graph_limits":[],"graph_stacked_disaggregation":"","graph_target_lines":[],"graph_title":"Hepatitis B incidence per 100,000 population","graph_titles":[],"graph_type":"line","indicator_name":"Hepatitis B incidence per 100,000 population","indicator_number":"3.3.4","national_geographical_coverage":"","page_content":"<b>Desired direction:</b> Decrease","permalink":"","precision":[],"progress_status":"alcanzado","reporting_status":"complete","sort":"","sources":[{"organisation":"Ministry of Health","periodicity":"Annual","url":"https://cne.isciii.es/en/services/department-of-communicable-diseases/diseases-a-z","url_text":"Compulsory notifiable diseases Statistics","logo":"/assets/img/fuentes/GE.png"}],"standalone":false,"tags":null,"indicador_disponible":"Hepatitis B incidence per 100,000 population","objetivo_global":"3- Ensure healthy lives and promote well-being for all at all ages","meta_global":"3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases","definicion":"Autochthonous cases of hepatitis B notified to the National Epidemiological Surveillance Network (RENAVE) per 100,000 inhabitants","formula":"\n$$TCA_{hepatitis B}^{t} = \\frac{CA_{hepatitis B}^{t}}{P^{t}} \\cdot 100.000$$\n\nwhere:\n\n$CA_{hepatitis B}^{t} =$ autochthonous cases of hepatitis B notified to the National Epidemiological Surveillance Network (RENAVE) in year $t$\n\n$P^{t} =$ population on July 1 of year $t$\n","desagregacion":"Sex","periodicidad":"Annual","observaciones":"Autochthonous cases are those in which the disease has been contracted in the national territory.","texto_oceca":"Indicator calculated using a methodology harmonised across the central statistical bodies of the autonomous communities","justificacion_global":"\nThe purpose is to describe the reduction in chronic hepatitis b infections. Most of the burden of disease \nfrom HBV infection comes from infections acquired before the age of 5 years. Therefore, prevention of \nHBV infection focuses on children under 5 years of age. The United Nations selected the cumulative \nincidence of chronic HBV infection at 5 years of age as an indicator of the Sustainable Development Goal \ntarget for \u201ccombating hepatitis\u201d. This indicator is measured indirectly through the proportion of children \n5 years of age who have developed chronic HBV infection (i.e. the proportion that tests positive for a \nmarker of infection called hepatitis B surface antigen [HBsAg]).\n\nThis indicator is measured indirectly through the proportion of children 5 years of age who have \ndeveloped chronic HBV infection (i.e. the proportion that tests positive for a marker of infection called \nhepatitis B surface antigen [HBsAg]). \n\nSource: United Nations Statistics Division\n","dato_global":"<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.3.4&seriesCode=SH_HAP_HBSAG&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=%3C5Y\">Prevalence of the Hepatitis B surface antigen (HBsAg) (%) SH_HAP_HBSAG</a> UNSTATS","comparabilidad":"The available indicator does not comply with United Nations metadata but provides similar information","indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-03-04.pdf\">Metadata 3-3-4.pdf</a>","national_data_updated_date":"2025-05-08","national_metadata_updated_date":"2025-06-18","es":{"indicador_disponible":"Hepatitis B incidence per 100,000 population","objetivo_global":"3- Ensure healthy lives and promote well-being for all at all ages","meta_global":"3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases","definicion":"Casos aut\u00f3ctonos de hepatitis B notificados a la Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE) por cada 100.000 habitantes","formula":"\n$$TCA_{hepatitis\\, B}^{t} = \\frac{CA_{hepatitis\\, B}^{t}}{P^{t}} \\cdot 100.000$$\n\ndonde:\n\n$CA_{hepatitis\\, B}^{t} =$ casos aut\u00f3ctonos de hepatitis B notificados a la Red Nacional de Vigilancia Epidemiol\u00f3gica (RENAVE) en el a\u00f1o $t$\n\n$P^{t} =$ poblaci\u00f3n a 1 de julio del a\u00f1o $t$\n","desagregacion":"Sex","periodicidad":"Annual","observaciones":"Los casos aut\u00f3ctonos son aquellos en los que la enfermedad se ha contra\u00eddo en el territorio nacional.","texto_oceca":"Indicator calculated using a methodology harmonised across the central statistical bodies of the autonomous communities","justificacion_global":"\nEl prop\u00f3sito es describir la reducci\u00f3n de las infecciones cr\u00f3nicas por hepatitis B. La mayor parte de la carga \nde enfermedad por infecci\u00f3n por VHB proviene de infecciones adquiridas antes de los 5 a\u00f1os de edad. Por lo tanto, \nla prevenci\u00f3n de la infecci\u00f3n por VHB se centra en ni\u00f1os menores de 5 a\u00f1os. Las Naciones Unidas seleccionaron \nel acumulado de la incidencia de infecci\u00f3n cr\u00f3nica por VHB a los 5 a\u00f1os de edad como indicador del objetivo de \n\u201ccombatir la hepatitis\u201d. Este indicador se mide indirectamente a trav\u00e9s de la proporci\u00f3n de ni\u00f1os 5 a\u00f1os de edad \nque han desarrollado una infecci\u00f3n cr\u00f3nica por VHB (es decir, la proporci\u00f3n que da positivo en una \nprueba marcador de infecci\u00f3n llamado ant\u00edgeno de superficie de la hepatitis B [HBsAg]).\n\nEste indicador se mide indirectamente a trav\u00e9s de la proporci\u00f3n de ni\u00f1os de 5 a\u00f1os que han desarrollado una \ninfecci\u00f3n cr\u00f3nica por VHB (es decir, la proporci\u00f3n que da positivo para un marcador de infecci\u00f3n llamado \nant\u00edgeno de superficie de la hepatitis B [HBsAg]). \n\nFuente: Divisi\u00f3n de Estad\u00edsticas de las Naciones Unidas \n","dato_global":"<a href=\"https://unstats.un.org/sdgs/dataportal/analytics/SingleSeries?indicators=3.3.4&seriesCode=SH_HAP_HBSAG&areaCode=  276,40,56,100,196,191,208,703,705,724,233,246,250,300,528,348,372,380,428,440,442,470,616,620,203,642,752,1,202,14,17,18,11,747,15,145,62,143,34,753,30,35,419,29,13,5,9,54,57,61,53,513,150,21,432,199,722&period=3&table=%3C5Y\">Prevalencia del ant\u00edgeno de superficie de la hepatitis B (HBsAg) (%) SH_HAP_HBSAG</a> UNSTATS","comparabilidad":"El indicador disponible no cumple con los metadatos de Naciones Unidas, pero aporta informaci\u00f3n similar","indicador_meta_enlace":"<a href=\"https://unstats.un.org/sdgs/metadata/files/Metadata-03-03-04.pdf\">Metadatos 3-3-4.pdf</a> (solo en ingl\u00e9s)"},"target_number":"3.3","goal_number":"3","indicator_sort_order":"03-03-04"}